Caspase-1 as Molecular Key in Cardiac Remodeling during Cardiorenal Syndrome Type 3 in the Murine Model.
Renal ischemia/reperfusion induces a systemic inflammatory response that is directly related to the development of cardiac hypertrophy due to cardiorenal syndrome type 3. Classic inflammatory pathways have been extensively investigated in cardiovascular diseases, including the participation of inflammasome in caspase-1-dependent IL-1β cleavage. In this study, we aim to understand how caspase-1 participates in cardiac remodeling induced by apoptosis. Wildtype and caspase-1 knockout animals were submitted to a renal ischemia/reperfusion protocol. Briefly, left kidney ischemia was induced in male C57BL/6 mice for 60 min, followed by reperfusion for 15 days. Gene expression has been investigated by Real Time PCR. Caspase activity was also evaluated. Lack of caspase-1 was sufficient to prevent the inflammatory response and cardiac dysfunction (such as an increase of QJ interval), however, caspase-1 knockout mice subjected to the renal ischemia/reperfusion protocol still developed cardiac hypertrophy. Assessment of caspase 3/7 and 9 activity suggests that the apoptotic response observed in this model is interleukin-1β-independent. The unexpected hypertrophy can be explained by the nuclear role of caspase-1 and inactivation of the transcription factor GATA-binding factor 4. Our data corroborates important findings on the role of caspase-1 in the development of cardiac hypertrophy and remodeling, even in the absence of inflammation.